IL-4Rα responsiveness of non-CD4 T cells contributes to resistance in Schistosoma mansoni infection in pan-T cell-specific IL-4Rα-deficient mice

American Journal of Pathology

Volumn 175, Issue 2, 2009, Pages 706-716

  Dewals, Benjamin ^a,b   Hoving, Jennifer C ^a   Leeto, Mosiuoa ^a   Marillier, Reece G ^a   Govender, Umeshree ^a   Cutler, Antony J ^a,c   Horsnell, William G C ^a   Brombacher, Frank ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; IMMUNOGLOBULIN E; INTERLEUKIN 4 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; EOSINOPHIL; FIBROSIS; GENE DELETION; GRANULOMATOUS HEPATITIS; HEALING; IMMUNOHISTOCHEMISTRY; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLAMMATION; INOCULATION; LEISHMANIASIS; LIVER GRANULOMA; LIVER INJURY; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCHISTOSOMIASIS MANSONI; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; GENETICS; GRANULOMA; IMMUNOLOGY; LEISHMANIA MAJOR; LIVER DISEASE; PARASITOLOGY; PATHOLOGY; SCHISTOSOMA MANSONI; SKIN LEISHMANIASIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GRANULOMA; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LIVER DISEASES; MICE; MICE, TRANSGENIC; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 68449087187     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090137     Document Type: Article

References (37)

1. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738
2. Brombacher F: The role of interleukin-13 in infectious diseases and allergy. Bioessays 2000, 22:646-656
3. Anthony RM, Rutitzky LI, Urban JF, Jr., Stadecker MJ, Gause WC: Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007, 7:975-987
4. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN: Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: iL-13 is a profibrotic agent. J Immunol 2000, 164:2585-2591
5. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, Leeto M, Kirsch R, Hall P, Mossmann H, Claussen B, Forster I, Brombacher F: Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004, 20:623-635
6. Hoffmann KF, Cheever AW, Wynn TA: IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 2000, 164:6406-6416
7. Kopf M, Brombacher F, Kohler G, Kienzle G, Widmann KH, Lefrang K, Humborg C, Ledermann B, Solbach W: IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med 1996, 184:1127-1136
8. Noben-Trauth N, Kropf P, Muller I: Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996, 271:987-990
9. Mohrs M, Ledermann B, Kohler G, Dorfmuller A, Gessner A, Brombacher F: Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic Leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 1999, 162:7302-7308
10. LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC: Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008, 132:259-272
11. Sacks D, Noben-Trauth N: The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002, 2:845-858
12. Locksley RM, Scott P: Helper T-cell subsets in mouse Leishmaniasis: induction, expansion and effector function. Immunol Today 1991, 12:A58-61
13. Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995, 13:151-177
14. Mohrs M, Holscher C, Brombacher F: Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect Immun 2000, 68:1773-1780
15. Holscher C, Arendse B, Schwegmann A, Myburgh E, Brombacher F: Impairment of alternative macrophage activation delays cutaneous Leishmaniasis in nonhealing BALB/c mice. J Immunol 2006, 176:1115-1121
16. Radwanska M, Cutler AJ, Hoving JC, Magez S, Holscher C, Bohms A, Arendse B, Kirsch R, Hunig T, Alexander J, Kaye P, Brombacher F: Deletion of IL-4R alpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. PLoS Pathog 2007, 3:e68
17. Pearce EJ, MacDonald AS: The immunobiology of schistosomiasis. Nat Rev Immunol 2002, 2:499-511
18. Wynn TA: Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004, 4:583-594
19. Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Ward JM, Cheever AW, Paul WE, Sher A: Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol 1999, 163:337-342
20. Kaplan MH, Whitfield JR, Boros DL, Grusby MJ: Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 1998, 160:1850-1856
21. Leeto M, Herbert DR, Marillier R, Schwegmann A, Fick L, Brombacher F: TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis. Am J Pathol 2006, 169:1701-1712
22. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Perez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM, Weaver WM, Kelso A, Jaenisch R, Wilson CB: A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001, 15:763-774
23. Garvin AM, Abraham KM, Forbush KA, Farr AG, Davison BL, Perlmutter RM: Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int Immunol 1990, 2:173-180
24. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996, 26:1553-1559
25. Boros DL, Warren KS: Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 1970, 132:488-507
26. Corraliza IM, Campo ML, Soler G, Modolell M: Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994, 174:231-235
27. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994, 265:103-106
28. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994, 12:635-673
29. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996, 380:630-633
30. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F: Conditional gene targeting. J Clin Invest 1996, 98:600-603
31. Horsnell WG, Brombacher F: Alternatively activated macrophages in experimental parasitic infections. Edited by LI Terrazas. Kerala, Research Signpost, 2007, pp 1-19
32. Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V: Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006, 116:2777-2790
33. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Eagle AR, Vats D, Brombacher F, Ferrante AW, Chawla A: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120
34. Herbert DR, Orekov T, Perkins C, Finkelman FD: IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 2008, 181:7214-7220
35. Chensue SW, Warmington KS, Hershey SD, Terebuh PD, Othman M, Kunkel SL: Evolving T cell responses in murine schistosomiasis. Th2 cells mediate secondary granulomatous hypersensitivity and are regulated by CD8+ T cells in vivo. J Immunol 1993, 151:1391-1400
36. Ragheb S, Boros DL: Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J Immunol 1989, 142:3239-3246
37. Yap G, Cheever A, Caspar P, Jankovic D, Sher A: Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni. Infect Immun 1997, 65:2583-2586